Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TRAIL antibody

This Rabbit Polyclonal antibody specifically detects TRAIL in WB, Func and EIA. It exhibits reactivity toward Human.
Catalog No. ABIN116275

Quick Overview for TRAIL antibody (ABIN116275)

Target

See all TRAIL (TNFSF10) Antibodies
TRAIL (TNFSF10) (Tumor Necrosis Factor (Ligand) Superfamily, Member 10 (TNFSF10))

Reactivity

  • 118
  • 39
  • 30
  • 8
  • 3
  • 1
Human

Host

  • 96
  • 50
  • 4
Rabbit

Clonality

  • 99
  • 51
Polyclonal

Conjugate

  • 85
  • 16
  • 13
  • 7
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TRAIL antibody is un-conjugated

Application

  • 111
  • 47
  • 36
  • 30
  • 27
  • 25
  • 13
  • 13
  • 9
  • 9
  • 8
  • 7
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Functional Studies (Func), Enzyme Immunoassay (EIA)
  • Specificity

    This antibody reacts with Human TRAIL/APO2 Ligand.

    Purification

    Affinity chromatography.

    Immunogen

    Highly pure (>98%) recombinant hTRAIL/Apo2L (humanTRAIL/Apo2L).
  • Application Notes

    Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhTRAIL/Apo2L (30 ng/mL), a concentration of 0.5-0.8 μg/mL of this antibody is required. ELISA: To detect hTRAIL/Apo2L by direct ELISA (using 100 l/well antibody solution) aconcentration of at least 0.5 μg/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with compatible secondary reagents, allows the detectionof 0.2 - 0.4 ng/well of recombinant hTRAIL/Apo2L. Western Blot: To detect hTRAIL/Apo2L by Western Blot analysis this antibody can be usedat a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondaryreagents the detection limit for recombinant hTRAIL/Apo2L is 1.5 - 3.0 ng/lane, under eitherreducing or non-reducing conditions.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Reconstitution

    Restore in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2 without preservatives.

    Preservative

    Without preservative

    Handling Advice

    Avoid repeated freezing and thawing. Centrifuge vial prior to opening!

    Storage

    4 °C/-20 °C

    Storage Comment

    Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
  • Target

    TRAIL (TNFSF10) (Tumor Necrosis Factor (Ligand) Superfamily, Member 10 (TNFSF10))

    Alternative Name

    CD253 / TRAIL

    Background

    Apoptosis or programmed cell death is induced in cells by a group of death domain containing receptors. Binding of ligand to these receptors sends signals that activate members of the caspase family of proteases. The signals ultimately cause degradation of chromosomal DNA by activating DNase. TRAIL (TNF related apoptosis induced ligand) or Apo 2L initiates apoptosis of tumor cells by binding to either of its receptors, DR4 or DR5. These receptors consist of an extracellular TRAIL binding domain and a cytoplasmic "death domain". In addition, two decoy receptors for TRAIL have also been identified. These receptors, designated DcR1 and DcR2, lack the death domain. Binding of TRAIL to either of these receptors, therefore, does not transmit the death signal. Thus, these receptors represent a novel way of regulating cell sensitivity to a pro-apoptotic cytokine at the cell surface. TRAIL is expressed predominantly in spleen, lung, and prostate but also in many other tissues.Synonyms: APO2L, Apo-2 ligand, Apo-2L, TNF-related apoptosis-inducing ligand, TNFSF10, Tumor necrosis factor ligand superfamily member 10

    Gene ID

    8743

    NCBI Accession

    NP_003801

    UniProt

    P50591

    Pathways

    Apoptosis, Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!